| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 01/17/2001 | EP1068185A1 Compounds with activity on muscarinic receptors |
| 01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
| 01/17/2001 | CN1280572A Inhibiting platelet derivative growth factor and/or quinoline and quinowoline compounds of P56lek tyrosinkinase |
| 01/17/2001 | CN1280569A 1,2-dihydro-2-oxoquinoline derivatives |
| 01/16/2001 | US6175011 Preparing aryloxy arylamides of pyridine-, pyrimidine-, pyrazine- and 1,3,5-triazine-carboxylic acids by reacting the heteroaromatic dihalide with an aromatic hydroxy then with carbon monoxide and an arylamine using diphosphine catalyst |
| 01/16/2001 | US6174905 As carcinostatic agent to a hematologic malignancy and a solid carcinoma |
| 01/16/2001 | US6174887 Amide compounds and use of the same |
| 01/11/2001 | WO2001002381A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/11/2001 | WO2001002372A1 Cyclized amino acid derivatives |
| 01/11/2001 | WO2001002371A1 Optically active piperazine compounds, intermediates for the preparation of the same and processes for the preparation of both |
| 01/11/2001 | WO2001002354A1 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method of using the same |
| 01/11/2001 | WO2001002349A1 Phenyl sulfamate derivatives |
| 01/11/2001 | WO2001002345A2 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 01/11/2001 | CA2375806A1 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 01/10/2001 | EP1066290A1 PYRROLO[1,2-a]PYRAZINE sPLA 2 INHIBITOR |
| 01/10/2001 | EP1066247A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 01/10/2001 | EP1066246A1 Novel cationic couplers and their use for oxidation dyeing |
| 01/10/2001 | EP1066245A1 Novel local anesthetic compounds and uses |
| 01/10/2001 | EP1066022A1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods |
| 01/10/2001 | CN1279682A bicyclic kinase inhibitors |
| 01/09/2001 | US6172229 1-phenyl-4-benzylpiperazines; dopamine receptor subtype specific ligands |
| 01/09/2001 | US6172065 Central nervous system disorders |
| 01/09/2001 | US6172058 Nervous system disorders; psychological disorders |
| 01/09/2001 | US6171522 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
| 01/04/2001 | WO2001000654A2 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 01/04/2001 | WO2001000578A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 01/04/2001 | WO2001000575A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same |
| 01/04/2001 | WO2001000214A1 Src kinase inhibitor compounds |
| 01/04/2001 | CA2377204A1 Purification and stabilization of peptide and protein pharmaceutical agents |
| 01/04/2001 | CA2376951A1 Src kinase inhibitor compounds |
| 01/04/2001 | CA2370500A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 01/03/2001 | EP1065203A2 Heterocyclic compounds as retinoic acid receptor antagonists |
| 01/03/2001 | EP1064274A1 Benzenesulfonamide derivatives and their use as medicaments |
| 01/03/2001 | CN1278807A Herbicidal N-alkenyl Heteroaryloxyacetamides |
| 01/03/2001 | CN1278721A IL-8 receptor antagonists |
| 01/03/2001 | CN1060172C Substituted biphenyl sulfonamide endothelin antagonists |
| 01/03/2001 | CN1060161C N-substituted phenylcarbamic acid derivatives, process for production thereof, agricultural and horticultural fungicides, intermediats of derlvatives and process for production thereof |
| 01/02/2001 | US6169095 For prevention and/or treatment of bradykinin or its analogues mediated diseases in the eye, such as allergy, inflammation and pain of the eye |
| 01/02/2001 | CA2068064C Fibrinogen receptor antagonists |
| 01/02/2001 | CA1341163C Oxime ether derivatives, their preparation and fungicides containing these derivatives |
| 01/02/2001 | CA1341159C Pure enantiomers of 4,5-disubstituted .alpha.-butyrolactams, process for their preparation, and their use |
| 12/28/2000 | WO2000078746A1 Antiviral agents |
| 12/28/2000 | WO2000078319A1 Dihydropyrazine derivatives as npy antagonists |
| 12/28/2000 | CA2377698A1 Dihydropyrazine derivatives as npy antagonists |
| 12/28/2000 | CA2375211A1 Antiviral agents |
| 12/27/2000 | EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 12/27/2000 | EP1062199A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 12/27/2000 | EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
| 12/27/2000 | CN1278244A Dipeptide nitriles |
| 12/27/2000 | CN1278242A Iron alkali salt of S, S-ethylenediamine-n,n'-disuccinic acid, and process for producing same |
| 12/26/2000 | US6166053 Antiproliferative agent for treating cancer |
| 12/26/2000 | US6166008 Treatment of schizophrenia with ampakines and neuroleptics |
| 12/26/2000 | US6166005 Heterocyclic metalloprotease inhibitors |
| 12/26/2000 | US6166004 Treatment of aids |
| 12/21/2000 | WO2000077519A1 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives |
| 12/21/2000 | WO2000077027A2 Serine protease inhibitors |
| 12/21/2000 | WO2000076984A2 Novel compounds, their use and preparation |
| 12/21/2000 | WO2000076980A1 Novel nitrogen-contaiing heterocyclic derivatives or salts thereof |
| 12/21/2000 | WO2000076976A1 Process for the production of 2-pyridylpyridine derivatives |
| 12/21/2000 | WO2000076974A2 Oligomers and polymers of cyclic imino carboxylic acids |
| 12/21/2000 | WO2000076971A2 Serine protease inhibitors |
| 12/21/2000 | WO2000076970A2 Serine protease inhibitors |
| 12/21/2000 | WO2000076957A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 12/21/2000 | WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 12/21/2000 | CA2383008A1 Compounds |
| 12/21/2000 | CA2375920A1 Compounds |
| 12/20/2000 | EP1060175A2 Tryptase inhibitors |
| 12/20/2000 | EP1060171A2 Tryptase inhibitors |
| 12/14/2000 | WO2000075121A2 Process for preparing 10,11-methanobenzosuberane derivatives |
| 12/14/2000 | WO2000075113A1 Novel heterocyclic carboxamide derivatives |
| 12/14/2000 | CA2378735A1 Process for preparing 10,11-methanobenzosuberane derivatives |
| 12/13/2000 | EP1058698A1 Preparation for prevention and healing of inflammation affections |
| 12/12/2000 | US6160126 Useful in preparing guanidine derivatives useful as insecticides and miticides |
| 12/12/2000 | US6160118 Process for the synthesis of substituted piperazinones via Mitsunobu reaction |
| 12/12/2000 | US6159995 Substituted diaminocarboxylic acids |
| 12/12/2000 | US6159980 Anxiolytic agents, antidepressants; psychological and eating disorders |
| 12/12/2000 | US6159978 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 12/07/2000 | WO2000073283A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 12/07/2000 | WO2000073260A1 Squaric acid derivatives as cell adhesion molecules |
| 12/07/2000 | WO2000072801A2 Alpha v integrin receptor antagonists |
| 12/07/2000 | CA2376024A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 12/07/2000 | CA2375218A1 Squaric acid derivatives as cell adhesion molecules |
| 12/07/2000 | CA2373937A1 Alpha v integrin receptor antagonists |
| 12/06/2000 | EP1057816A1 Method for producing heteroaromatic aldehydes |
| 12/06/2000 | EP1056728A1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines |
| 12/06/2000 | EP1056727A1 Solid support synthesis of 2-oxopiperazines |
| 12/06/2000 | CN1275981A Novel pharmaceutically active compounds, their preparation and use as ECE-inhibitors |
| 12/05/2000 | US6156895 Using chiral hydrogenation, intermediate for an hiv protease inhibitor. |
| 12/05/2000 | US6156761 Substituted tetralone derivatives for enhancing cognition |
| 11/30/2000 | WO2000071572A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 11/30/2000 | WO2000071518A2 Heterocyclic analgesic compounds and their use |
| 11/30/2000 | WO2000071516A2 INHIBITORS OF FACTOR Xa |
| 11/30/2000 | WO2000071515A2 INHIBITORS OF FACTOR Xa |
| 11/30/2000 | WO2000071506A2 Naphthalene ureas as glucose uptake enhancers |
| 11/30/2000 | WO2000032583A9 Antitumor dibenzofluorene derivatives |
| 11/30/2000 | CA2374788A1 Inhibitors of factor xa |
| 11/30/2000 | CA2374225A1 Naphthalene ureas as glucose uptake enhancers |
| 11/30/2000 | CA2372887A1 Heterocyclic analgesic compounds and their use |
| 11/30/2000 | CA2371904A1 Inhibitors of factor xa |
| 11/29/2000 | EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |